课题基金 / 基金详情

项目摘要

项目成果

CHRISTY TREJO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):乳腺癌是女性癌症死亡的第二大原因。亚型根据组织病理学表现和基因表达进行分类。基底亚型预后差,部分原因是缺乏治疗策略。基底部肿瘤具有独特的特征,如高度的基因组不稳定性、肿瘤内异质性和与乳腺干细胞相似的基因表达谱。这些特征可能通过正常干细胞的异常增殖而产生。或者,这种亚型中常见的突变可能会促进干细胞样状态。为了研究这些可能性,需要对纯的干细胞群体进行表征。乳腺中的干细胞活性在胚胎发育后期变得可检测到,在出生前达到峰值,出生后迅速减少,并在成人中保持较低水平。胎儿乳腺干细胞(fMaSC)通过表达与成人乳腺干细胞(aMaSC)相同的标志物来分离,并且在移植后类似地能够再生腺体。有趣的是,富集fMaSC而非aMaSC的群体的基因表达谱显示出与基底肿瘤的基因表达谱的显著重叠。当fMaSC被靶向与基础肿瘤相关的突变并移植到受体小鼠中时,肿瘤在五周内出现。移植了携带相同突变的aMaSC的小鼠在六个月后尚未发生乳腺肿瘤。这些数据表明,fMaSC非常容易发生肿瘤,并且可能是基底样肿瘤的来源。Lgr5在fMaSC中在其活性的峰值处高度表达。Lgr5+胎儿细胞代表体外测量的fMaSC的最富集群体。将在整个开发过程中分析Lgr5+细胞,以测量干细胞潜能。将跟踪Lgr 5+胎儿和成体细胞的命运,以测试胎儿样干细胞在成体龟头中的持久性。将在整个发育过程中生成Lgr5+细胞的综合基因表达谱,以鉴定与干细胞状态相关的基因。在Lgr5+ fMaSC的高度富集群体中,将进行单细胞RNA测序以细化这些特征。这将允许鉴定亚群和标记物,用于其前瞻性分离和功能分析。细胞类型和突变对基因组不稳定性和肿瘤内异质性的相对贡献知之甚少。将测试处于不同发育阶段的干细胞在靶向该亚型中常见的突变时产生基底样肿瘤的能力。将分析肿瘤的基因组不稳定性、肿瘤内异质性和基因表达。通过定义干细胞状态的分子相关性并测试发育如何影响肿瘤表型,将测试胎儿乳腺干细胞是基底肿瘤来源的假设。这项分析将揭示正常发育与肿瘤发生和进展之间的联系,为乳腺癌治疗策略提供见解。
英文摘要
DESCRIPTION (provided by applicant): Breast cancer is the second leading cause of cancer death in women. Subtypes are classified by histopathological appearance and gene expression. The basal subtype has a poor prognosis due in part to lack of therapeutic strategies. Basal tumors have unique characteristics such as high degrees of genomic instability, intra-tumor heterogeneity, and gene expression profiles similar to those of mammary stem cells. These characteristics may arise through the aberrant propagation of normal stem cells. Alternatively, mutations commonly found in this subtype may promote a stem-like state. To investigate these possibilities, pure populations of stem cells need to be characterized. Stem cell activity in the mammary gland becomes detectable in late embryonic development, peaks right before birth, diminishes rapidly after birth, and remains low in the adult. Fetal mammary stem cells (fMaSCs) are isolated by expression of the same markers as adult mammary stem cells (aMaSCs), and are similarly able to regenerate glands upon transplantation. Interestingly, gene expression profiles of populations enriched for fMaSCs, but not aMaSCs, show striking overlap with those of basal tumors. When fMaSCs were targeted with basal tumor-associated mutations and transplanted into a recipient mouse, a tumor arose within five weeks. Mice transplanted with aMaSCs bearing the same mutation have yet to develop mammary tumors after six months. These data suggest that fMaSCs are highly prone to tumorigenesis and may be a source of basal-like tumors. Lgr5 is highly expressed in fMaSCs at the peak of their activity. Lgr5+ fetal cells represent the most enriched population of fMaSCs measured in vitro. Lgr5+ cells will be analyzed throughout development to measure stem cell potential. The fate of Lgr5+ fetal and adult cells will be followed to test for the persistence of fetal-like stem cells in the adult glan. Comprehensive gene expression profiles from Lgr5+ cells will be generated throughout development to identify genes associated with a stem cell state. In the highly enriched population of Lgr5+ fMaSCs, single cell RNA sequencing will be conducted to refine these signatures. This will allow the identification of subpopulations and markers for their prospective isolation and functional analysis. The relative contributions of cell type and mutation to genomic instability and intra-tumor heterogeneity are poorly understood. The capacity of stem cells at various stages of development to give rise to basal-like tumors when targeted with mutations commonly found in this subtype will be tested. Tumors will be analyzed for genomic instability, intra-tumor heterogeneity, and gene expression. By defining the molecular correlates of a stem cell state and testing how development influences tumor phenotype, the hypothesis that fetal mammary stem cells are a source of basal tumors will be tested. This analysis will reveal links between normal development and tumor initiation and progression, providing insight into strategies for breast cancer treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular and functional analysis of mammary stem cells throughout development
海外基金